Tag: Healthcare Policy
Biden’s Medicare Advantage Regulation Boosts Payments to Insurers
Biden's Medicare Advantage Regulation Boosts Payments to Insurers In a groundbreaking move that could reshape the landscape of the Medicare Advantage industry, President Biden's Centers for Medicare and Medicaid Services recently unveiled a...
Trump’s FDA and NIH Picks, FDA Office Crunch: Pharmalittle Update
As the week comes to a close, many of us are looking forward to some well-deserved rest and relaxation. Personally, I'm excited to spend time with loved ones, walk my furry friends, and enjoy...
Millions Uninsured as Medicaid Programs Reduce Coverage: New Data
Millions of Americans have found themselves without health insurance coverage as state Medicaid programs have reduced their coverage, leading to an increase in the national uninsured rate from 7.7% to 8.2% earlier this year,...
Medicaid Official Criticizes Republican Reform as Poor Policy
Medicaid, a program that provides health coverage to millions of low-income Americans, is facing potential cuts as Republicans look to fund tax cuts and other priorities. The outgoing Medicaid chief under the Biden administration...
Navigating the GOP’s Healthcare Agenda: Balancing Health and Insurance
RFK Jr.'s Unconventional Stance on Health Insurance In a surprising turn of events, Robert F. Kennedy Jr., known for his Make American Healthy Again movement, has been chosen by President Trump to lead the Department...
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee policy. Pitts, who served as the senior official in charge...
2024 Election: Understanding the Political Impact of Mifepristone
Hello readers of D.C. Diagnosis! Hope you all had a great Olympic season. If you have any news or tips to share, feel free to send them to our email. Let's dive into the...
Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs
Medicare to Negotiate Prices of Diabetes and Weight Loss Drugs In a groundbreaking move, Medicare officials have announced plans to negotiate the prices of two widely-used drugs for diabetes and weight loss. Ozempic and Wegovy,...
Trump’s Approach to Drug Pricing Plan: What to Expect
President Trump is like totally gonna try to push this “most-favored nation” policy next week to like bring down drug prices in the U.S. It’s gonna shake things up for sure, especially for the...
RFK Jr.’s Stem Cell Deregulation Roundtable: Red Flags Raised
Renowned cell biology and human anatomy professor at UC Davis School of Medicine, Paul Knoepfler, introduces a new column, Lab Dish, focusing on regenerative medicine. The recent roundtable on regenerative medicine hosted by Health...
Maryland Governor Signs Law Expanding State’s Prescription Drug Affordability Board Powers
In a pretty big deal, Maryland Gov. Wes Moore went ahead and signed this bill that lets a state board keep working on making prescription drugs cheaper for everyone in the state, not just...
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program
Sanofi Faces Federal Threats Over Payment Terms Change for Drug Discount Program A recent warning from a U.S. government agency has put pharmaceutical giant Sanofi in hot water over its decision to alter payment terms...
